Furthermore, the ILK pathway was found to cross-talk with the KRAS pathway via a KRAS-ILK-hnRNPA1 regulatory loop in pancreatic cancer [72] as well as in lung adenocarcinoma [73]. This evidence concerns the gene KRAS and familial pancreatic carcinoma.